| abstract |
Disclosed are methods for treating, preventing and managing pulmonary hypertension. Certain methods include immunomodulatory compounds or pharmaceutically acceptable salts, solvates (eg, hydrates), stereoisomers, clathrates, or prodrugs, either alone or as a second active agent, surgery. And / or administration in combination with lung transplantation. Certain second active agents are those that can reduce pulmonary artery pressure. Also disclosed are pharmaceutical compositions, single unit dosage forms, and kits suitable for use in the methods of the invention. [Selection figure] None |